Rituximab as first-line treatment of patients with follicular lymphoma (FL) and a low-burden tumor: Clinical and molecular evaluation.

被引：0
|
作者：
Solal-Celigny, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Lacotte, L
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoulas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Mathieu-Boue, A
Benzohra, A
Colombat, P
机构：
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2802
引用
收藏
页码：631A / 631A
页数：1
相关论文
共 50 条
  • [1] Rituximab as first-line monotherapy in low-grade follicular lymphoma with a low tumor burden
    Solal-Céligny, P
    ANTI-CANCER DRUGS, 2001, 12 : S11 - S14
  • [2] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation
    Colombat, P
    Salles, G
    Brousse, N
    Eftekhari, P
    Soubeyran, P
    Delwail, V
    Deconinck, E
    Haïoun, C
    Foussard, C
    Sebban, C
    Stamatoullas, A
    Milpied, N
    Boué, F
    Taillan, B
    Lederlin, P
    Najman, A
    Thièblemont, C
    Montestruc, F
    Mathieu-Boué, A
    Benzohra, A
    Solal-Céligny, P
    BLOOD, 2001, 97 (01) : 101 - 106
  • [3] Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma
    De la Cruz Vicente, Fatima
    Carrillo-Cruz, Estrella
    Sole Rodriguez, Maria
    Marin Niebla, Ana
    Martino Galiana, Maria Luz
    Falantes Gonzalez, Jose
    Montero Cuadrado, Isabel
    Gonzalez Campos, Jose
    Espigado Tocino, Ildefonso
    Rios-Herranz, Eduardo
    Antonio Perez-Simon, Jose
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 469 - 475
  • [4] Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
    Cartron, Guillaume
    Bachy, Emmanuel
    Tilly, Herve
    Daguindau, Nicolas
    Pica, Gian-Matteo
    Bijou, Fontanet
    Mounier, Christiane
    Clavert, Aline
    Damaj, Gandhi Laurent
    Slama, Borhane
    Casasnovas, Olivier
    Houot, Roch
    Bouabdallah, Krimo
    Sibon, David
    Fitoussi, Olivier
    Morineau, Nadine
    Herbaux, Charles
    Gastinne, Thomas
    Fornecker, Luc-Matthieu
    Haioun, Corinne
    Launay, Vincent
    Araujo, Carla
    Benbrahim, Omar
    Sanhes, Laurence
    Gressin, Remy
    Gonzalez, Hugo
    Morschhauser, Franck
    Ternant, David
    Xerri, Luc
    Tarte, Karin
    Pranger, Delphine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (19) : 3523 - +
  • [5] A multicenter randomized trial of Fludarabine and Mitoxantrone (FM) plus Rituximab versus CHOP plus Rituximab as first-line treatment in patients with follicular lymphoma (FL).
    Zinzani, PL
    BLOOD, 2002, 100 (11) : 93A - 93A
  • [6] SINGLE AGENT RITUXIMAB IS A VALID OPTION FOR FIRST-LINE TREATMENT IN FOLLICULAR LYMPHOMA
    Ghielmini, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 81 - 81
  • [7] Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Schiattone, Luana
    Bartalucci, Giulia
    Bocchia, Monica
    LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2997 - 2998
  • [8] FIRST LINE TREATMENT WITH BENDAMUSTINE-RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Buenasmananas Cervantes, D.
    Calle Primo, C.
    Nebro Luque, M. dM
    Hernandez Ruiz, B.
    HAEMATOLOGICA, 2015, 100 : 266 - 266
  • [9] SAFETY AND EFFICACY OF RITUXIMAB AND CHLORAMBUCIL IN COMBINATION AS FIRST-LINE TREATMENT IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS
    Martinelli, G.
    Andreola, G.
    Laszlo, D.
    Minga, P.
    Cannella, L.
    Liptrott, S.
    Sammassimo, S.
    Linetti, M.
    Calabrese, L.
    Bassi, S.
    HAEMATOLOGICA, 2012, 97 : 651 - 652
  • [10] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (07)
12345